Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

NCT00643643 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Maraviroc (UK-427,857)
DRUG: Maraviroc (UK-427,857)
DRUG: Maraviroc (UK-427,857)
DRUG: Maraviroc (UK-427,857)
OTHER: Placebo

Sponsor

ViiV Healthcare

Collaborators

[object Object]